Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 279.95
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Auro Laboratories Ltd. engages in the business of dealing active pharmaceutical ingredients. The firm also offers bulk drugs. The company was founded on May 26, 1989 and is headquartered in Mumbai, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Data is available to registered users only
Buy
Sell